323 related articles for article (PubMed ID: 32499642)
1. A lower X-gate in TASK channels traps inhibitors within the vestibule.
Rödström KEJ; Kiper AK; Zhang W; Rinné S; Pike ACW; Goldstein M; Conrad LJ; Delbeck M; Hahn MG; Meier H; Platzk M; Quigley A; Speedman D; Shrestha L; Mukhopadhyay SMM; Burgess-Brown NA; Tucker SJ; Müller T; Decher N; Carpenter EP
Nature; 2020 Jun; 582(7812):443-447. PubMed ID: 32499642
[TBL] [Abstract][Full Text] [Related]
2. TRESK background potassium channel is not gated at the helix bundle crossing near the cytoplasmic end of the pore.
Lengyel M; Czirják G; Enyedi P
PLoS One; 2018; 13(5):e0197622. PubMed ID: 29763475
[TBL] [Abstract][Full Text] [Related]
3. Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein.
Gierten J; Ficker E; Bloehs R; Schlömer K; Kathöfer S; Scholz E; Zitron E; Kiesecker C; Bauer A; Becker R; Katus HA; Karle CA; Thomas D
Br J Pharmacol; 2008 Aug; 154(8):1680-90. PubMed ID: 18516069
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K
Wiedmann F; Schulte JS; Gomes B; Zafeiriou MP; Ratte A; Rathjens F; Fehrmann E; Scholz B; Voigt N; Müller FU; Thomas D; Katus HA; Schmidt C
Basic Res Cardiol; 2018 Jun; 113(4):27. PubMed ID: 29881975
[TBL] [Abstract][Full Text] [Related]
5. Identification of the A293 (AVE1231) Binding Site in the Cardiac Two-Pore-Domain Potassium Channel TASK-1: a Common Low Affinity Antiarrhythmic Drug Binding Site.
Wiedmann F; Kiper AK; Bedoya M; Ratte A; Rinné S; Kraft M; Waibel M; Anad P; Wenzel W; González W; Katus HA; Decher N; Schmidt C
Cell Physiol Biochem; 2019; 52(5):1223-1235. PubMed ID: 31001961
[TBL] [Abstract][Full Text] [Related]
6. Acid-sensitive TWIK and TASK two-pore domain potassium channels change ion selectivity and become permeable to sodium in extracellular acidification.
Ma L; Zhang X; Zhou M; Chen H
J Biol Chem; 2012 Oct; 287(44):37145-53. PubMed ID: 22948150
[TBL] [Abstract][Full Text] [Related]
7. The molecular basis for an allosteric inhibition of K
Rinné S; Kiper AK; Vowinkel KS; Ramírez D; Schewe M; Bedoya M; Aser D; Gensler I; Netter MF; Stansfeld PJ; Baukrowitz T; Gonzalez W; Decher N
Elife; 2019 Feb; 8():. PubMed ID: 30803485
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic TWIK-Related Acid-Sensitive K+ Channel (TASK-1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model.
Wiedmann F; Beyersdorf C; Zhou X; Büscher A; Kraft M; Nietfeld J; Walz TP; Unger LA; Loewe A; Schmack B; Ruhparwar A; Karck M; Thomas D; Borggrefe M; Seemann G; Katus HA; Schmidt C
J Am Heart Assoc; 2020 May; 9(10):e015751. PubMed ID: 32390491
[TBL] [Abstract][Full Text] [Related]
9. TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes.
Rinné S; Kiper AK; Schlichthörl G; Dittmann S; Netter MF; Limberg SH; Silbernagel N; Zuzarte M; Moosdorf R; Wulf H; Schulze-Bahr E; Rolfes C; Decher N
J Mol Cell Cardiol; 2015 Apr; 81():71-80. PubMed ID: 25655935
[TBL] [Abstract][Full Text] [Related]
10. Gating of two pore domain potassium channels.
Mathie A; Al-Moubarak E; Veale EL
J Physiol; 2010 Sep; 588(Pt 17):3149-56. PubMed ID: 20566661
[TBL] [Abstract][Full Text] [Related]
11. A Small-Molecule Compound Selectively Activates K2P Channel TASK-3 by Acting at Two Distant Clusters of Residues.
Tian F; Qiu Y; Lan X; Li M; Yang H; Gao Z
Mol Pharmacol; 2019 Jul; 96(1):26-35. PubMed ID: 31015283
[TBL] [Abstract][Full Text] [Related]
12. Protein and Chemical Determinants of BL-1249 Action and Selectivity for K
Pope L; Arrigoni C; Lou H; Bryant C; Gallardo-Godoy A; Renslo AR; Minor DL
ACS Chem Neurosci; 2018 Dec; 9(12):3153-3165. PubMed ID: 30089357
[TBL] [Abstract][Full Text] [Related]
13. Selectivity filter instability dominates the low intrinsic activity of the TWIK-1 K2P K
Nematian-Ardestani E; Abd-Wahab F; Chatelain FC; Sun H; Schewe M; Baukrowitz T; Tucker SJ
J Biol Chem; 2020 Jan; 295(2):610-618. PubMed ID: 31806709
[TBL] [Abstract][Full Text] [Related]
14. Heterodimerization of two pore domain K+ channel TASK1 and TALK2 in living heterologous expression systems.
Suzuki Y; Tsutsumi K; Miyamoto T; Yamamura H; Imaizumi Y
PLoS One; 2017; 12(10):e0186252. PubMed ID: 29016681
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels.
Staudacher K; Staudacher I; Ficker E; Seyler C; Gierten J; Kisselbach J; Rahm AK; Trappe K; Schweizer PA; Becker R; Katus HA; Thomas D
Br J Pharmacol; 2011 Jul; 163(5):1099-110. PubMed ID: 21410455
[TBL] [Abstract][Full Text] [Related]
16. New Targets for Old Drugs: Cardiac Glycosides Inhibit Atrial-Specific K
Schmidt C; Wiedmann F; Gaubatz AR; Ratte A; Katus HA; Thomas D
J Pharmacol Exp Ther; 2018 Jun; 365(3):614-623. PubMed ID: 29643254
[TBL] [Abstract][Full Text] [Related]
17. Gating, Regulation, and Structure in K2P K+ Channels: In Varietate Concordia?
Niemeyer MI; Cid LP; González W; Sepúlveda FV
Mol Pharmacol; 2016 Sep; 90(3):309-17. PubMed ID: 27268784
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the human two-pore domain potassium channel K2P1.
Miller AN; Long SB
Science; 2012 Jan; 335(6067):432-6. PubMed ID: 22282804
[TBL] [Abstract][Full Text] [Related]
19. K
Lolicato M; Arrigoni C; Mori T; Sekioka Y; Bryant C; Clark KA; Minor DL
Nature; 2017 Jul; 547(7663):364-368. PubMed ID: 28693035
[TBL] [Abstract][Full Text] [Related]
20. Elucidating the Structural Basis of the Intracellular pH Sensing Mechanism of TASK-2 K
Bustos D; Bedoya M; Ramírez D; Concha G; Zúñiga L; Decher N; Hernández-Rodríguez EW; Sepúlveda FV; Martínez L; González W
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
